Hemp Business Journal
January 22, 2019
CBD, Still A Restricted Substance By Jeffrey Finkle On December 20th the 2019 Farm Bill was signed into law by President Trump, with overwhelming bipartisan support […]
October 31, 2018
By Sean Murphy, Director of Hemp Analytics, New Frontier Data Investors are waking up to the hemp industry. Hemp is proving its opportunity for financial returns, […]
October 7, 2018
By J.J. McCoy, Senior Managing Editor, for New Frontier Data Recent news that the U.S. Drug Enforcement Agency (DEA) is rescheduling cannabidiol (CBD) for use in […]
September 22, 2018
By J.J. McCoy, Senior Managing Editor, for New Frontier Data Even before word of the DEA’s landmark rescheduling of cannabidiol (CBD) for GW Pharmaceutical’s FDA-approved Epidiolex, […]
September 19, 2018
By William Sumner, Hemp Business Journal Contributor The potential both practical and profitable for cannabidiol (CBD) has been gaining an increasing amount of national attention. From […]
September 11, 2018
California’s crackdown on CBD in food may be toothless By J.J. McCoy, Senior Managing Editor for New Frontier Data In July, the California Department of Public […]
August 18, 2018
The CBD Report 2018: Industry Outlook, details how the U.S. CBD industry grew nearly 40% in 2017, reaching $367 million in sales across both hemp-derived and […]
August 5, 2018
By J.J. McCoy, Senior Managing Editor for New Frontier Data As California works out the kinks in its new if long-anticipated adult-use market, and Canada prepares […]
July 1, 2018
The FDA last week approved UK-based GW Pharmaceuticals’ Epidiolex, a “pure plant-derived CBD” extract shown to drastically reduce seizures in children with epileptic syndromes. Marking the […]